These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 15340883)

  • 1. Interaction of food supplement L-carnitine with oral anticoagulant acenocoumarol.
    Bachmann HU; Hoffmann A
    Swiss Med Wkly; 2004 Jun; 134(25-26):385. PubMed ID: 15340883
    [No Abstract]   [Full Text] [Related]  

  • 2. Functional food: a growing and not clearly controlled market with a risk potential ranging from a food to a drug.
    Pletscher W
    Swiss Med Wkly; 2004 Jun; 134(25-26):367-8. PubMed ID: 15340879
    [No Abstract]   [Full Text] [Related]  

  • 3. Spontaneous spinal hemorrhage complicating anticoagulant therapy.
    Badaoui R; Koukougnon M; El kettani C; Ouendo M; Rekik R; Tchaoussoff J
    Can J Anaesth; 2003; 50(7):750-1. PubMed ID: 12944455
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effectiveness and safety of oral anticoagulation treatment with acenocoumarol in non-valvular atrial fibrillation].
    Castro C; Bustos L; Ocampo R; Molina E; Cabrero P; Vergara R; Lanas F
    Rev Med Chil; 2017 Oct; 145(10):1243-1251. PubMed ID: 29488564
    [No Abstract]   [Full Text] [Related]  

  • 5. Rosuvastatin-acenocoumarol interaction.
    Mondillo S; Ballo P; Galderisi M
    Clin Ther; 2005 Jun; 27(6):782-4. PubMed ID: 16117985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Labyrinthine haemorrhage secondary to oral anticoagulants.
    Arellano B; Brea B; González FM
    Acta Otorrinolaringol Esp; 2016; 67(3):185-6. PubMed ID: 26277739
    [No Abstract]   [Full Text] [Related]  

  • 7. Interaction between amorolfine and acenocoumarol.
    Morales-Molina JA; Fayet-Pérez A; Martínez-Plata E; Pérez-Moyano R; Molina-Arrebola MA
    Eur J Clin Pharmacol; 2012 Dec; 68(12):1687-8. PubMed ID: 22648278
    [No Abstract]   [Full Text] [Related]  

  • 8. Probable interaction between acenocoumarol and levofloxacin: a case series.
    Palacios-Zabalza I; Bustos-Martínez M; Peral-Aguirregoitia J; Martínez-Bengoechea MJ; Aguirre Gomez C
    J Clin Pharm Ther; 2015 Dec; 40(6):693-5. PubMed ID: 26394892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Warfarin or acenocoumarol: which is better in the management of oral anticoagulants?
    Barcellona D; Vannini ML; Fenu L; Balestrieri C; Marongiu F
    Thromb Haemost; 1998 Dec; 80(6):899-902. PubMed ID: 9869157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acenocoumarol and pregnancy outcome in a patient with mitral valve prosthesis: a case report.
    Stefanidis K; Papoutsis D; Daskalakis G; Loutradis D; Antsaklis A
    Fetal Diagn Ther; 2009; 25(1):115-8. PubMed ID: 19270459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic quality control of oral anticoagulant therapy comparing the short-acting acenocoumarol and the long-acting phenprocoumon.
    Gadisseur AP; van der Meer FJ; Adriaansen HJ; Fihn SD; Rosendaal FR
    Br J Haematol; 2002 Jun; 117(4):940-6. PubMed ID: 12060134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and effectiveness of low dose oral vitamin K1 administration in asymptomatic out-patients on warfarin or acenocoumarol with excessive anticoagulation.
    Poli D; Antonucci E; Lombardi A; Gensini GF; Abbate R; Prisco D
    Haematologica; 2003 Feb; 88(2):237-8. PubMed ID: 12604423
    [No Abstract]   [Full Text] [Related]  

  • 13. [The anticoagulant treatment of patients with heart valve prostheses].
    Cristodorescu R; Brânzan L; Szvantek C; Drăgulescu S; Anderca I; Streian C
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1989; 41(4):343-52. PubMed ID: 2573944
    [No Abstract]   [Full Text] [Related]  

  • 14. Reconsidering combined antiplatelet and anticoagulant therapy in atrial fibrillation.
    Falk RH
    J Am Coll Cardiol; 2004 Oct; 44(8):1567-9. PubMed ID: 15489086
    [No Abstract]   [Full Text] [Related]  

  • 15. [Increased INR from concomitant use of acenocoumarol and capecitabine].
    Tomlow B; Voll ML; Smorenburg CH
    Ned Tijdschr Geneeskd; 2012; 156(26):A4793. PubMed ID: 22759711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of polymorphisms of VKORC1 and CYP2C9 on major gastrointestinal bleeding risk in anticoagulated patients.
    Montes R; Nantes O; Alonso A; Zozaya JM; Hermida J
    Br J Haematol; 2008 Dec; 143(5):727-33. PubMed ID: 18950464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated recombinant factor VII to reverse oral anticoagulants for emergent cesarean delivery.
    Morante L; Guasch EV; Palacio F; Gilsanz F
    Anesth Analg; 2006 Jun; 102(6):1902-3. PubMed ID: 16717350
    [No Abstract]   [Full Text] [Related]  

  • 18. Triflusal versus oral anticoagulation for primary prevention of thromboembolism after bioprosthetic valve replacement (trac): prospective, randomized, co-operative trial.
    Aramendi JI; Mestres CA; Martinez-León J; Campos V; Muñoz G; Navas C
    Eur J Cardiothorac Surg; 2005 May; 27(5):854-60. PubMed ID: 15848326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Oral anticoagulation with vitamin K antagonists].
    Alberio L
    Ther Umsch; 2003 Jan; 60(1):5-9. PubMed ID: 12638470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abrupt versus gradual withdrawal of vitamin K antagonist treatment in patients with venous thromboembolic disease: assessment of hypercoagulability and clinical outcome.
    de Groot MR; Njo TL; van Marwijk Kooy M; Büller HR
    Clin Lab; 2000; 46(11-12):575-81. PubMed ID: 11109505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.